[RUNX1-突变急性髓性白血病患者的临床特征]
Y X Dong1, W J Dai1, W Q Zhang1
1Department of Hematology and the Diagnosis and Treatment Center for Hematologic Diseases of the Second Affiliated Hospital of Anhui Medical University, Anhui Medical University Hematology Research Center, Hefei 230601, China.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
|February 9, 2026
概括
急性髓性白血病 (AML) 患者的RUNX1突变与年龄较大,缓解率较低和生存时间较短有关. 这些在AML中常见的突变显著恶化了患者的预后和治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- RUNX1突变与各种血液性恶性瘤有关.
- 了解急性髓性白血病 (AML) 中RUNX1突变的预后意义对于治疗分层至关重要.
研究的目的:
- 调查新诊断的AML患者中RUNX1突变的流行率和临床影响.
- 分析RUNX1突变状态,同时发生的突变和患者结果之间的相关性.
主要方法:
- 在2018年2月至2023年5月期间诊断出323名AML患者的回顾性分析.
- 评估RUNX1突变状态,共突变 (ASXL1,DNMT3A,FLT3-ITD,NPM1) 和临床特征.
- 基于RUNX1突变状态和频率的完全缓解,复发,死亡率,总生存率 (OS) 和无复发生存率 (RFS) 的比较.
主要成果:
- 在11.5%的AML患者中发现了RUNX1突变,经常与ASXL1同时发生,但与NPM1.1相互排斥.
- 患有RUNX1突变的患者年龄较大,完全缓解率较低 (39.4%vs79.8%),复发率 (75.0%vs48.8%) 和死亡率 (91.4%vs59.5%) 较高.
- RUNX1突变与显著缩短的OS (5.9 vs 20.1个月) 和RFS (9.5 vs 46.5个月) 相关. 高突变频率进一步恶化了结果.
- 与DNMT3A或ASXL1和FLT3-ITD同时发生的RUNX1突变表明预后较差.
结论:
- RUNX1突变是AML显著的负预后因素,与不良的临床特征和较低的存活率相关.
- 与RUNX1突变一起出现DNMT3A,ASXL1或FLT3-ITD等共突变,进一步加剧了不良预后.
- 治疗策略需要考虑RUNX1突变状态在AML个性化治疗方法.
相关概念视频
Mutations
94.6K
Overview
94.6K
Mutations
44.6K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Acute Pancreatitis II: Clinical Manifestations and Management
889
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
889
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
447
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
447
Acute Kidney Injury III: Clinical Manifestations
979
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
979
Viral Mutations
40.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K


